This principle was shown to enhance bone marrow homing in a xenograft lymphoma model using NK-92 cells treated ex vivo with human Alpha-(1,3)-fucosyltransferase (Fut6) and GDP-fucose [171]. The gene discussed is FUT6; the disease is lymphoma.